Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR4 | P51679 | 4/20 | 0.64 |
| ▸ | FLT3 | P36888 | 11/20 | 0.61 |
| ▸ | MELK | Q14680 | 4/20 | 0.57 |
| ▸ | BTK | Q06187 | 2/20 | 0.53 |
| ▸ | ERBB4 | Q15303 | 2/20 | 0.53 |
| ▸ | LYN | P07948 | 1/20 | 0.53 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.53 |
| ▸ | FER | P16591 | 1/20 | 0.53 |
| ▸ | MATK | P42679 | 1/20 | 0.53 |
| ▸ | BLK | P51451 | 1/20 | 0.53 |
| ▸ | BMX | P51813 | 1/20 | 0.53 |
| ▸ | TEK | Q02763 | 1/20 | 0.53 |
| ▸ | CAMK2G | Q13555 | 1/20 | 0.53 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.53 |
| ▸ | CAMK1 | Q14012 | 1/20 | 0.53 |
| ▸ | CSK | P41240 | 1/20 | 0.49 |
| ▸ | CAMK1G | Q96NX5 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3533991 | 1.00 | CCR4 (0.64) | CCR4FLT3MELKBTKERBB4 | |
| SCHEMBL3542860 | 0.91 | CCR4 (0.63) | CCR4FLT3MELKBTKERBB4 | |
| SCHEMBL3542859 | 0.91 | CCR4 (0.63) | CCR4FLT3MELKBTKERBB4 | |
| SCHEMBL3539191 | 0.87 | CCR4 (0.64) | CCR4FLT3MELKBTKERBB4 | |
| SCHEMBL3539192 | 0.87 | CCR4 (0.64) | CCR4FLT3MELKBTKERBB4 | |
| SCHEMBL3544092 | 0.78 | BTK (0.64) | CCR4FLT3MELKBTKERBB4 | |
| SCHEMBL3544088 | 0.78 | BTK (0.64) | CCR4FLT3MELKBTKERBB4 | |
| SCHEMBL13783483 | 0.78 | FLT3 (0.73) | CCR4FLT3MELKBTKERBB4 | |
| SCHEMBL3536852 | 0.77 | FLT3 (0.71) | CCR4FLT3MELKBTKERBB4 | |
| SCHEMBL3536853 | 0.77 | FLT3 (0.71) | CCR4FLT3MELKBTKERBB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7829566-B2 | Such as (7-chloro-2-styryl-quinazolin-4-yl)-(3-imidazol-1-yl-propyl)-amine; glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents | MEDERSKI WERNER | 2010-11-09 | — | — | US | disclosed |
| US-20070293667-A1 | 4-Amino-quinazolines | MEDERSKI WERNER | 2007-12-20 | — | — | US | disclosed |
| US-20040044204-A1 | 4-amino-quinazolines | ORTHO-MCNEIL PHARMACEUTICALS, INC. | 2004-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040044204-A1 | 4-amino-quinazolines | MRGPRX4, MRGPRX1, MRGPRX2 | CCR4 896/4885FLT3 493/4885MELK 4356/4885 |
| US-20070293667-A1 | 4-Amino-quinazolines | MRGPRX4, MRGPRX1, MRGPRX2 | CCR4 1320/4885FLT3 224/4885MELK 4278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.